A novel class of drugs
confident of single strands of DNA or RNA, called aptamers, can bind protein targets with a high substantiate and specificity and are currently in clinical growth as treatments for a broad range of common diseases, as described in a inclusive review article published online ahead of print in Oligonucleotides, a peer-reviewed journal published by Mary Ann Liebert, Inc.

More: - Read the rest here